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Abstract
T lymphocytes play a critical role in cell-mediated immune responses. During activation, extracellular and intracellular
signals alter T cell metabolism in order to meet the energetic and biosynthetic needs of a proliferating, active cell, but
control of these phenomena is not well defined. Previous studies have demonstrated that signaling from the costimulatory
receptor CD28 enhances glucose utilization via the phosphatidylinositol-3-kinase (PI3K) pathway. However, since CD28
ligation alone does not induce glucose metabolism in resting T cells, contributions from T cell receptor-initiated signaling
pathways must also be important. We therefore investigated the role of mitogen-activated protein kinase (MAPK) signaling
in the regulation of mouse T cell glucose metabolism. T cell stimulation strongly induces glucose uptake and glycolysis,
both of which are severely impaired by inhibition of extracellular signal-regulated kinase (ERK), whereas p38 inhibition had a
much smaller effect. Activation also induced hexokinase activity and expression in T cells, and both were similarly
dependent on ERK signaling. Thus, the ERK signaling pathway cooperates with PI3K to induce glucose utilization in
activated T cells, with hexokinase serving as a potential point for coordinated regulation.
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Introduction
T cells are dependent on external supplies of glucose to
maintain biosynthesis and energy metabolism during activation.
Activated T cells adopt a metabolic state of ‘‘aerobic glycolysis’’, in
which glucose flux through glycolysis is high, but only a small
proportion of the glucose is oxidized in mitochondria [1–5]. A
similar phenomenon was recognized in tumor cells more than 80
years ago [6], and was originally thought to represent a defect in
mitochondrial function, perhaps as a result of mutations that
occurred during oncogenic transformation. However, more recent
interpretations suggest that glycolysis is a preferred metabolic
pathway for highly proliferative cells, and the shift to a glycolytic
phenotype is part of a larger adaptive metabolic program to
support growth and proliferation [7–9]. Although there is growing
appreciation for the importance of metabolic control in both
immune responses and tumor development, the pathways that
regulate glucose metabolism are still not well defined.
Resting lymphocytes depend upon growth signals from cy-
tokines and low-level T cell receptor (TCR) stimulation in order to
maintain metabolic homeostasis [10,11], whereas CD28 costim-
ulation is required for induction of high level glucose uptake and
glycolysis, in large part via activation of the phosphatidylinositol-
3-kinase (PI3K)/Akt signaling pathway [12,13]. The inhibitory
receptors cytotoxic T lymphocyte antigen-4 (CTLA-4) and pro-
grammed death-1 (PD-1) both block CD28-induced Akt activa-
tion, and also prevent the increase in glucose utilization [12,14],
suggesting that regulation of cellular metabolism might be a
component of the inhibitory function of these receptors. Strikingly,
overexpression of glucose transporter 1 (GLUT1), the major
glucose transporter in hematopoietic cells [10], can partially re-
place costimulation in the induction of proliferation and cytokine
production, and constitutively active Akt synergizes with GLUT1
overexpression [13]. Together, these findings indicate the impor-
tance of enhanced glucose utilization as a downstream effect of
CD28 signaling. However, ligation of CD28 alone does not induce
glucose metabolism [12]. Thus, TCR-initiated signaling pathways
must cooperate with PI3K/Akt signaling to regulate glucose
metabolism.
Ligation of the TCR triggers a variety of signaling cascades,
several of which are candidates to regulate metabolism. Three key
mitochondrial matrix enzymes, pyruvate dehydrogenase, isocitrate
dehydrogenase, and a-ketoglutarate dehydrogenase, are sensitive
to calcium levels [15]. This suggests that the rapid influx of
calcium that occurs after TCR stimulation may regulate Krebs
cycle activity, particularly given the recent evidence that calcium
influx in T cells is linked to coordinated mitochondrial calcium
uptake [16]. However, since most glucose metabolism in T cells
does not utilize the Krebs cycle, it is likely that metabolic
regulation by calcium would be more important for alternative
Krebs cycle substrates, such as glutamine [17–22]. The mitogen-
activated protein kinase (MAPK) signaling pathways are also
activated by TCR stimulation, and have been implicated in
control of glucose metabolism in other cell types, particularly in
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15425enhancing glycolysis [23–25]. We therefore investigated the role of
MAPK signaling in T cell glucose metabolism. We found that the
enhanced glucose uptake and glycolysis seen in activated T cells is
dependent on extracellular signal-regulated kinase (ERK) signal-
ing, and that this may be due to the regulation of hexokinase
expression and activity.
Results
Activation of murine T cells leads to enhanced glucose
metabolism
Studies with human peripheral blood T cells have shown that
stimulation via mitogenic lectins or CD3/CD28 ligation leads to
an "aerobic glycolysis" phenotype, highly inducing glucose uptake
and glycolysis [2,12,14,26,27]. In order to further characterize the
regulation of glucose metabolism in T lymphocytes, we decided to
switch to the murine system. This would allow us to take
advantage of the many genetic and biochemical tools available in
the murine system, as well as the lower sample-to-sample
variability offered by inbred mouse strains. To confirm that
glucose metabolism in murine T cells follows an induction pattern
similar to that seen in human T cells, we purified splenic T cells
from C57BL/6 mice and stimulated them in vitro with anti-CD3
and anti-CD28 antibodies. After 24 hours of stimulation, glucose
uptake by live T cells was measured by the accumulation of
radiolabeled 2-deoxyglucose, a non-metabolizable glucose analog,
and glycolysis was measured by the generation of
3H-labeled H2O
from
3H-labeled glucose, at the step catalyzed by enolase. As
shown in Figure 1, activated murine T cells increased both glucose
uptake and glycolysis. Thus, primary mouse T cells upregulate
glucose utilization upon CD3/CD28 ligation similarly to human T
cells, and comparably to previous studies using mitogenic lectins.
The ‘‘aerobic glycolysis’’ phenotype was originally described in
tumor cells [6]. For comparison, we therefore also examined
glycolysis in the murine T lymphoma cell line EL-4. EL-4 cells
showed a high rate of glycolysis without any TCR stimulation,
generally 2–3 times the rate of activated T cells (Figure 2A). This is
similar to what we have recently reported for glutamine utilization
in EL-4 cells [22]. Thus, in the absence of TCR or CD28 ligation,
EL-4 cells display elevated metabolism compared to even fully
activated primary T cells. We next tested whether stimulation of
EL-4 cells with anti-CD3 and anti-CD28 antibodies would further
enhance glycolysis. As shown in Figure 2B, stimulation did not
appreciably alter glycolysis in EL-4 cells, indicating that regulation
of glucose metabolism has become unlinked from CD3/CD28
signaling.
Glucose metabolism in activated T cells is regulated by
MAPK signaling
Work from several groups has established the importance of the
PI3K/Akt pathway in regulating lymphocyte glucose metabolism
[12,13,28], in addition to its well-known role in insulin receptor-
mediated increases in glucose transport [29–34]. However,
although cross-linking CD28 alone is sufficient to activate PI3K
and Akt [35], it is not sufficient to increase glucose metabolism in
the absence of TCR/CD3 signaling [12]. Together, these indicate
that additional, TCR-induced signaling is required to cooperate
with CD28-induced PI3K signals. We therefore examined other
signal transduction pathways for regulation of glucose metabolism
in activated T cells.
Ligation of the T cell receptor initiates numerous intracellular
signaling pathways, including cascades that lead to the activation
of MAPK family members. Although well established as regulators
of transcription factors during T cell activation, the MAPK
pathways have also been implicated in control of amino acid [36–
38] and glucose [24,25] utilization in other cell types. We therefore
tested the importance of ERK and p38 in the control of glucose
metabolism during T cell activation. T cells were stimulated for
24 hours in the presence or absence of specific inhibitors for each
of the MAPK pathways, and the effects on glucose uptake and
glycolysis were determined. As shown in Figure 3A, the
stimulation-induced increase in glucose uptake was almost
completely blocked by the ERK inhibitor U0126 (82.2%
inhibition), but only partially blocked by the p38 inhibitor
SB203580 (51% inhibition). Inhibitors were all used at concen-
trations that completely blocked T cell proliferation (data not
shown) and which do not inhibit other kinases (2.6 mM U0126
[39], and 20 mM SB203580 [40]). As shown in Figure 3B, ERK
blockade also largely prevented the induction of glycolysis (76.7%
inhibition), whereas p38 inhibition had a much smaller effect on
glycolysis (19.3% inhibition). Thus, glucose metabolism appears to
Figure 1. Activation induces an ‘‘aerobic glycolysis’’ phenotype
in mouse T cells. Purified T cells were cultured with either control
hamster IgG (resting) or anti-CD3 plus anti-CD28 antibodies (stimulat-
ed). Glucose uptake (A) and glycolysis (B) rates were measured after
24 hours. ***p,0.0001, means are different; **, p,0.001, means are
different. Results are representative of at least 3 independent
experiments.
doi:10.1371/journal.pone.0015425.g001
Glucose Metabolism in T Lymphocytes
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than p38.
MAPK signaling controls hexokinase activity
Glucose uptake and subsequent metabolism are dependent on
hexokinase function. Phosphorylation of glucose to glucose-6-
phosphatetrapsglucoseinthecell,andremovesitfromequilibrium,
allowing continued diffusion through glucose transporters. Glucose-
6-phosphate is also the initial substrate for glycolysis. Therefore,
hexokinase is well positioned to be a common regulation point.
Usinganassayfortotalenzymeactivity,wecomparedhexokinasein
resting and activate T cells. As shown in Figure 4A, CD3/CD28
stimulation of T cells strongly increased total cellular hexokinase
activity. As with glycolysis, hexokinase activity was high in EL-4
lymphoma cells in the absence of any TCR stimulation (Figure 4B).
The hexokinase activity in EL-4 cells was substantially higher than
glycolysis rate, which was unlike our findings for primary T cells
(compare Figure 1B to 4A for primary cells, and Figure 2 to 4B for
EL-4). The disproportionately high hexokinase activity (relative to
glycolysis) inEL-4 cellsmayreflecta largedemand intumorcells for
glucose utilizationvia othermetabolic pathways, suchasthepentose
phosphate shunt [41], although a deeper analysis of glucose
metabolism in tumor cells would be required to draw definitive
conclusions.
Figure 2. Lymphoma cells show constitutively high glycolysis.
(A) Glycolysis was measured in EL-4 lymphoma cells from continuous
culture, without additional stimulation. Glycolysis in resting and
stimulated T cells (as described in Figure 1) was measured for com-
parison. p,0.001, means that do not share a letter differ. (B) EL-4 cells
were cultured for 24 hours with either control hamster IgG (unstimu-
lated) or anti-CD3 plus anti-CD28 antibodies (stimulated) and glycolysis
rates were measured. ns, not significantly different. Results are
representative of 2 (A) or 3 (B) independent experiments.
doi:10.1371/journal.pone.0015425.g002
Figure 3. Glucose metabolism in T cells is regulated by MAPK
signaling. Purified T cells were stimulated in the absence or presence
of the ERK inhibitor U0126 (2.6 mM) or the p38 inhibitor SB203580
(20 mM) for 24 hours. Glucose uptake (A) and glycolysis (B) were
measured as in Figure 1. p,0.05, means that do not share a letter differ.
Results are representative of 3 independent experiments.
doi:10.1371/journal.pone.0015425.g003
Glucose Metabolism in T Lymphocytes
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uptake and glycolysis, we asked whether induction of hexokinase
also required MAPK signaling. We focused on ERK, as inhibition
of this pathway had much greater effects than p38 inhibition on
uptake and glycolysis. In addition, ERK has been reported to
positively regulate hexokinase in cultured cells [23]. Using the
ERK inhibitor U0126, we found that induction of hexokinase
activity downstream of TCR/CD28 ligation was strongly
dependent on ERK signaling (Figure 5), similar to glucose uptake
and glycolysis. Comparable results were seen using a second ERK
inhibitor, PD98059 (data not shown). Thus, by regulating
hexokinase activity, the ERK signaling pathway is able to control
glucose metabolism in a coordinated fashion.
We recently reported that ERK positively regulates mRNA
expression of the enzyme glutaminase, which catalyzes the first
step in glutamine metabolism [22]. We therefore tested whether
ERK signaling in T cells also induces hexokinase gene expression,
Figure 4. T cell activation induces hexokinase activity. (A) Resting
or 24-hour stimulated T cells were lysed in 0.1% Triton X-100 and
enzymatic activity of hexokinase was measured. ***p,0.0001, means are
different. (B) Continuously growing EL-4 cells were lysed in 0.1% Triton X-
100 and hexokinase activity was compared to that in resting and 24-hour
stimulated T cells. p,0.0001, means that do not share a letter differ.
Results are representative of 3 (A) or 2 (B) independent experiments.
doi:10.1371/journal.pone.0015425.g004
Figure 5. Hexokinase activity in activated T cells is regulated
by MAPK signaling. (A) T cells were stimulated in the absence or
presence of the ERK inhibitor U0126 (2.6 mM), as in Figure 3, and
hexokinase activity was measured. p,0.05, means that do not share a
common letter differ. (B) T cells were cultured with control (rest) or anti-
CD3 and anti-CD28 antibodies for the indicated times, in the absence
(stim) or presence of 40 mM PD98059 (stim + PD). Hexokinase 1 (left
panel) and hexokinase 2 (right panel) mRNA levels were determined by
quantitative real-time PCR. p,0.05, means that do not share a common
letter differ. Results are representative of 3 (hexokinase 1) or 2
(hexokinase 2) independent experiments.
doi:10.1371/journal.pone.0015425.g005
Glucose Metabolism in T Lymphocytes
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study glutaminase expression. T cell stimulation increased mRNA
levels of hexokinase 1 and 2 within 3 hours, and hexokinase 2
consistently showed higher and longer-lived induction than
hexokinase 1 (Figure 5B). Stimulation of T cells in the presence
of 40 mM PD98059, another highly specific ERK inhibitor [42],
ablated the increase in hexokinase 1 mRNA expression, and
partially blocked the increase in hexokinase 2 mRNA (Figure 5B).
Thus, glucose metabolism in T cells appears to be regulated, at
least partly, by ERK control of hexokinase gene expression.
Discussion
T cell activation is accompanied by a large increase in glucose
uptake and glycolysis, which is necessary to support new metabolic
demands. Previous studies have shown that the enhanced glucose
utilization is dependent on signals from the costimulatory receptor
CD28, and particularly the PI3K/Akt pathway [12,14]. However,
CD28 ligation alone does not induce changes in glucose
metabolism, despite strongly activating PI3K and Akt [12,35],
implicating TCR-initiated signaling in this process as well. In this
study, we found that the MAPK family member ERK plays an
important role in the regulation of glucose metabolism during T
cell activation, while p38 makes a smaller (and perhaps redundant)
contribution. Blockade of ERK signaling strongly inhibited
increases in glucose uptake and glycolysis. High level glucose
metabolism has been shown to be required for the survival,
proliferation, and cytokine production (especially IFN-c)o f
activated T cells [13,43]. Thus, in addition to regulating gene
expression via the activation of transcription factors, ERK also
controls T cell function by enhancing glucose metabolism.
Glucose metabolism is controlled by a combination of allosteric
activatorsand inhibitors,as wellasbypost-translational modification
of key enzymes. This provides a variety of potential targets for
MAPKregulation.Hexokinase,which catalyzesthe phosphorylation
of glucose to glucose-6-phosphate, is a highly attractive candidate,
for several reasons. Glucose uptake in lymphocytes occurs by
facilitated diffusion through GLUT1, meaning that glucose can only
move down a concentration gradient. Upon phosphorylation by
hexokinase,glucoseisremoved fromequilibrium and simultaneously
trapped inside the cell. Thus, glucose uptake is critically dependent
on hexokinase activity. In addition, phosphorylation is a required
step for both glucose storage as glycogen, and glucose catabolism via
glycolysis and the pentose phosphate pathway. Thus, hexokinase is
likely to be a gatekeeper for cellular glucose consumption. We found
that resting T cells have low hexokinase activity, which is highly
induced upon activation. Strikingly, hexokinase activity levels
corresponded closely to glycolysis rates, reinforcing the idea that
hexokinase represents a limiting factor for glucose metabolism in T
cells. As with glucose uptake and glycolysis, induction of hexokinase
activity was dependent on ERK signaling, providing a point for
coordinated control of glucose metabolism.
The finding that hexokinase activity in T cells is regulated by
MAPK signaling also provides insight into the cooperation between
the TCR and CD28 in enhancing glucose utilization. Studies of the
mechanism of growth factor receptor inhibition of cell death
revealed that hexokinase is a target of Akt, with evidence that Akt
can both induce subcellular redistribution and increase enzymatic
activity of hexokinase [44,45]. Thus, the CD28 signal (Akt) and
TCR signals (ERK) intersect at hexokinase. It is unknown whether
hexokinase is a direct phosphorylation target for Akt or ERK, but
regulation of hexokinase activity by ERK in glomerular mesangial
cells appears to require de novo gene transcription [23], consistent
with our own finding that induction of hexokinase gene expression
during T cell activation is inhibited by blocking ERK signaling.
However, we also found that expression of hexokinase 2 was only
partially dependent on ERK, suggesting that the mechanism may
involve changes in both hexokinase expression level and post-
translational modifications. Further investigation will be necessary
to sort out these possibilities.
A model of aerobic glycolysis, with glutamine serving as a
critical Krebs cycle substrate, has been proposed to be a common
feature of most or all rapidly growing and dividing cells, including
tumor cells [7–9]. Indeed, we found that the EL-4 T lymphoma
cell line demonstrates a pattern of glucose metabolism that is
similar to that of activated primary T cells, but with the various
aspects of glucose utilization further elevated. This is also similar to
what we recently reported for glutamine metabolism in EL-4 cells
vs. activated normal T cells [22]. Thus, the metabolic alterations
that have long been observed in tumors (and which are now used
diagnostically to detect cancer) may not be due to metabolic
dysfunction, but rather may represent an adaptation in which
increases in cellular metabolism occur without the normal
requirement for receptor-mediated induction.
Materials and Methods
Ethics Statement
Animals used in this study received humane care in strict
compliance with the ‘‘Guide for the Care and Use of Laboratory
Animals’’ of the National Institutes of Health. All protocols were
approved by the Institutional Animal Care and Use Committee of
the University of Maryland (Permit Number R-09-70).
Antibodies and reagents
Anti-CD3 (mAb 145-2C11) and anti-CD28 (mAb 37.51)
antibodies, control hamster IgG, and phycoerythrin-labeled anti-
Thy1.2 antibodies were purchased from eBioscience (San Diego,
CA). U0126, PD98059, and SB203580 were purchased from
Biomol (Plymouth Meeting, PA). Hexokinase (Enzyme Commis-
sion 2.7.1.1) was from MP Biomedicals (Santa Ana, CA). Glucose-
6-phosphate dehydrogenase (Enzyme Commission 1.1.1.49), ATP,
and NADPH were from Sigma-Aldrich (St. Louis, MO). 3-
mercapto-1,2-propanediol (thioglycerol) was purchased from
Fisher Scientific (Fairlawn, NJ). [
3H]-2-deoxyglucose, 5-[
3H]-
glucose, and [
3H]-H2O were from PerkinElmer (Shelton, CT).
Animals
C57BL/6J mice (6 weeks old) were purchased from The Jackson
Laboratory (Bar Harbor, ME). All mice were maintained in
ventilated microisolator cages (Animal Care Systems, Centennial,
CO) in the University of Maryland animal facility. Mice were
euthanized by carbon dioxide inhalation, as recommended by the
American Veterinary Medical Association Panel on Euthanasia,
and all efforts were made to minimize suffering.
T cell purification
Murine T cells were purified from spleens using the EasySep
Mouse T Cell Enrichment Kit (Stem Cell Technologies,
Vancouver, BC, Canada) or the Dynal Mouse T Cell Negative
Isolation Kit (Invitrogen, Carlsbad, CA) according to the
manufacturer’s protocol. Purified T cells were generally .95%
Thy1-positive, as determined by flow cytometry.
Cell lines and culture
The murine EL-4 thymoma cell line was purchased from
American Type Tissue Collection (Manassas, VA). All cells were
maintained in RPMI1640 medium (Mediatech, Manassas, VA)
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streptomycin, 10 mM HEPES buffer, 2 mM glutamine, and
55 mM 2-mercaptoethanol at 37uC in a 5% CO2 atmosphere.
T cell stimulation
Anti-CD3 and anti-CD28 antibodies were covalently attached
to tosyl-activated Dynabeads (Invitrogen) following the manufac-
turer’s instructions. Beads were mixed with T cells at a 3:1 ratio of
beads:cells and incubated at 37uC for the desired time. For
unstimulated samples, T cells were mixed with control hamster
IgG-linked Dynabeads, and were then cultured in parallel with
stimulated samples. For experiments with MAPK inhibitors, the
inhibitors were added to culture medium at the time of
stimulation, and were present throughout the incubation.
Glucose uptake, glycolysis, and hexokinase assays
Glucose uptake and glycolysis were measured as described
previously [12]. To measure hexokinase activity, purified T cells
were lysed in 0.1% Triton X-100 at a concentration of
2610
8 cells/mL, and 5 mL of lysate was used for each reaction.
The assay was carried out as described by Rathmell et al.[45], in a
final volume of 100 mL. Activity was determined by the change in
absorbance at 340 nm, using a VersaMax spectrophotometer and
SoftMax Pro software (Molecular Devices). OD readings were
taken every 6–10 s for at least 30 minutes, and rate was calculated
from the linear portion of the curve. A340 values were converted
into substrate concentrations using Beer’s Law (A=eLc, where A
is absorption, e is the extinction coefficient, L is the path length,
and c is concentration) and the extinction coefficient of NAD(P)H
(6.22 mM
21 cm
21). Data points for all analyses are presented as
the mean of triplicate samples 6 S.D.
Real-time PCR
Total RNA was extracted from unstimulated or stimulated T
cells using the Nucleospin RNA II kit (Macherey-Nagel, Du ¨ren,
Germany) or the RNeasy Mini kit (Qiagen, Valencia, CA). cDNA
was generated using iScript reverse transcriptase reagents (Bio-
Rad, Hercules, CA). Primers for real-time PCR were designed
using the Primer-BLAST tool of the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/), and were as follows: hexokinase 1, forward 59 GC-
CACGCTCGGTGCCATCTT 39, reverse 59 GGTCTTGTGG-
AACCGCCGGG 39; hexokinase 2, forward 59 AGCTCTGTG-
GCGCAGGCATG 39, reverse 59 TCGGACAGGCCACAGCA-
GTG 39. Real-time PCR was performed in an iCycler iQ system
(Bio-Rad) using the SensiMix SYBR & Fluorescein kit (Bioline,
Taunton, MA) and analyzed with MyiQ software (Bio-Rad). Melt
curve analysis was performed to confirm the presence of a single
PCR product for each reaction, and agarose gel electrophoresis
was used to confirm that PCR products were the expected sizes.
Fold induction was calculated by the DDCt method, using 18S
rRNA as the reference. Data are presented as the means of
triplicate samples 6 SD.
Statistics
All statistical analyses were performed using Prism Version 5
software (GraphPad, San Diego, CA). The minimal level of
confidence at which experimental results were considered
significant was p,0.05. Statistical significance between samples
was determined by one-way analysis of variance (ANOVA) with
Bonferroni post-test analysis, or by two-tailed t test.
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